This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Pregabalin and Radicular Pain Study (PARPS)

Sponsored by Singapore General Hospital

About this trial

Last updated 14 years ago

Study ID

#2006/072/A

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
20 to 80 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 15 years ago

What is this trial about?

This study is designed to investigate the effectiveness of pregabalin (Lyrica) on nerve pain caused by degenerative neck problems. Pregabalin is a new drug registered for use in nerve pain worldwide

What are the participation requirements?

Yes

Inclusion Criteria

- Clinical & MRI, or electrophysiological evidence of pain due to radiculopathy

- Patients with CS and CSR or CSM with neuropathic pain due to the above in the neck and upper limbs or lower limbs (including dysesthesia, paresthesia, hyperalgesia).

No

Exclusion Criteria

- Diabetic neuropathy or other underlying neuropathic conditions

- Contraindications and allergy to pregabalin

- Previously treated with gabapentin in the last 8 weeks

- Pregnant or breast feeding

- History of renal impairment

- History of other causes of neuropathic pain